Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"
As of the date of this press release, Solventum expresses no opinion and is neutral toward TRC's tender offer but cautions stockholders to monitor the trading price of the Solventum stock and any amendment to the offer price and to review the terms and conditions to the tender offer carefully. There is no guarantee the conditions of the offer will be satisfied.
Solventum stockholders who have already tendered their shares may withdraw them at any time by providing notice in the manner described in the TRC offering documents prior to the expiration of the offer, which is currently scheduled for
Solventum does not endorse TRC's unsolicited mini-tender offer. Solventum is not affiliated or associated in any way with TRC, its mini-tender offer, or its mini-tender offer documents.
TRC's mini-tender offer is not subject to many of the disclosure and procedural requirements of
Solventum urges stockholders to obtain current market quotations for their shares of stock, to consult their broker or financial advisor, and to exercise caution with respect to TRC's offer. Solventum requests that a copy of this news release be included with all distributions of materials relating to TRC's mini-tender offer related to Solventum's stock.
About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-cautions-investors-regarding-trc-capitals-mini-tender-offer-302166740.html
SOURCE Solventum